Hero-Approach

Today’s news. Tomorrow’s story.

News

News articles by MTIP

MTIP has sucessfully exited Blueprint Genetics
22/01/2020
MTIP has sucessfully exited Blueprint Genetics

MTIP has successfully exited Blueprint Genetics to Quest Diagnostics. Together, Quest Diagnostics, the world’s leading provider of diagnostic information services, and Blueprint Genetics will broaden access to actionable insights in genetic and rare diseases, improving patient care and pharmaceutical drug research and development. Financial terms of the transaction were not disclosed.
New MTIP investment in Oviva
15/01/2020
New MTIP investment in Oviva

MTIP has invested in Oviva, the leading digital provider of Type 2 diabetes treatment in Europe.
2nd Annual MTIP Healthcare Clinic
18/04/2019
2nd Annual MTIP Healthcare Clinic

Basel, April 9th, 2019 MTIP presented their audience a journey through a great portfolio, a view point on future developments in the healthcare sector as well as an exciting outlook of the future steps and the key terms of the MTIP Fund ll.
How to pitch to a Life Science VC Investor
05/02/2019
How to pitch to a Life Science VC Investor

Pitching a venture capital fund is not an easy exercise for many entrepreneurs because you may never get a second chance to make a good first impression.

Press and media articles

Your Contact Person

MTIP Jessica Di Palo

Jessica Di Palo

Head of Marketing and Communications

communications@mtip.ch